Short interest in Aclaris Therapeutics Inc (NASDAQ:ACRS) increased during the last reporting period, rising from 1.39M to 2.41M. This put 4.03% of the company's publicly available shares short.

Short interest for Aclaris Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Aclaris Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 1.12M shares traded per day, it would take 2.16 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.